-
1
-
-
77954954894
-
-
GLOBOCAN 2002. Descriptive Epidemiology Group, International Agency for Research on Cancer. Lyon, France.:, 2002. Accessed 21 Jan 2010
-
Fearly J. GLOBOCAN 2002. Descriptive Epidemiology Group, International Agency for Research on Cancer. Lyon, France.: www-dep. iarc.fr/; 2002. Accessed 21 Jan 2010.
-
-
-
Fearly, J.1
-
2
-
-
0033959520
-
Cancer statistics, 2000
-
Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin. 2000;50:7-33.
-
(2000)
CA Cancer J. Clin.
, vol.50
, pp. 7-33
-
-
Greenlee, R.T.1
Murray, T.2
Bolden, S.3
Wingo, P.A.4
-
3
-
-
6944230093
-
Colon cancer survival rates with the new American joint committee on cancer sixth edition staging
-
O'Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst. 2004;96:1420-5.
-
(2004)
J. Natl. Cancer Inst.
, vol.96
, pp. 1420-1425
-
-
O'Connell, J.B.1
Maggard, M.A.2
Ko, C.Y.3
-
4
-
-
0025060806
-
Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma
-
Moertel CG, Fleming TR, Macdonald JS, et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med. 1990;322:352-8.
-
(1990)
N. Engl. J. Med.
, vol.322
, pp. 352-358
-
-
Moertel, C.G.1
Fleming, T.R.2
Macdonald, J.S.3
-
5
-
-
0028956045
-
Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: A final report
-
Moertel CG, Fleming TR, Macdonald JS, et al. Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report. Ann Intern Med. 1995;122:321-6.
-
(1995)
Ann. Intern. Med.
, vol.122
, pp. 321-326
-
-
Moertel, C.G.1
Fleming, T.R.2
Macdonald, J.S.3
-
6
-
-
36849064682
-
Adjuvant chemotherapy versus observation in patients with colorectal cancer: A randomised study
-
Quasar Collaborative G, Gray R, Barnwell J, et al. Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. Lancet. 2007;370:2020-9.
-
(2007)
Lancet
, vol.370
, pp. 2020-2029
-
-
Collaborative, G.Q.1
Gray, R.2
Barnwell, J.3
-
7
-
-
0037566566
-
Cancer of the large bowel
-
Mayo C. Cancer of the large bowel. Med Sentinel. 1904;12:466-73.
-
(1904)
Med. Sentinel
, vol.12
, pp. 466-473
-
-
Mayo, C.1
-
8
-
-
0037266824
-
The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined
-
Swanson RS, Compton CC, Stewart AK, Bland KI. The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol. 2003;10:65-71.
-
(2003)
Ann. Surg. Oncol.
, vol.10
, pp. 65-71
-
-
Swanson, R.S.1
Compton, C.C.2
Stewart, A.K.3
Bland, K.I.4
-
9
-
-
0017331560
-
An approach for the treatment of penile carcinoma
-
Cabanas RM. An approach for the treatment of penile carcinoma. Cancer. 1977;39:456-66.
-
(1977)
Cancer
, vol.39
, pp. 456-466
-
-
Cabanas, R.M.1
-
10
-
-
17144420503
-
Identification of sentinel nodes in patients with colon cancer
-
Dahl K, Westlin J, Kraaz W, et al. Identification of sentinel nodes in patients with colon cancer. Eur J Surg Oncol. 2005;31:381-5.
-
(2005)
Eur. J. Surg. Oncol.
, vol.31
, pp. 381-385
-
-
Dahl, K.1
Westlin, J.2
Kraaz, W.3
-
11
-
-
3042756948
-
Sentinel lymph node mapping technique in colon cancer
-
Saha S, Dan AG, Beutler T, et al. Sentinel lymph node mapping technique in colon cancer. Semin Oncol. 2004;31:374-81.
-
(2004)
Semin. Oncol.
, vol.31
, pp. 374-381
-
-
Saha, S.1
Dan, A.G.2
Beutler, T.3
-
12
-
-
33646851253
-
Sentinel node lymphocytes: Tumour reactive lymphocytes identified intraoperatively for the use in immunotherapy of colon cancer
-
Marits P, Karlsson M, Dahl K, et al. Sentinel node lymphocytes: tumour reactive lymphocytes identified intraoperatively for the use in immunotherapy of colon cancer. Br J Cancer. 2006;94:1478-84.
-
(2006)
Br. J. Cancer
, vol.94
, pp. 1478-1484
-
-
Marits, P.1
Karlsson, M.2
Dahl, K.3
-
13
-
-
29044444695
-
Detection of immune responses against urinary bladder cancer in sentinel lymph nodes
-
Marits P, Karlsson M, Sherif A, et al. Detection of immune responses against urinary bladder cancer in sentinel lymph nodes. Eur Urol. 2006;49:59-70.
-
(2006)
Eur. Urol.
, vol.49
, pp. 59-70
-
-
Marits, P.1
Karlsson, M.2
Sherif, A.3
-
14
-
-
41549128459
-
Metinel node-the first lymph node draining a metastasis-contains tumor-reactive lymphocytes
-
Dahl K, Karlsson M, Marits P, et al. Metinel node-the first lymph node draining a metastasis-contains tumor-reactive lymphocytes. Ann Surg Oncol. 2008;15:1454-63.
-
(2008)
Ann. Surg. Oncol.
, vol.15
, pp. 1454-1463
-
-
Dahl, K.1
Karlsson, M.2
Marits, P.3
-
15
-
-
0035925638
-
Adjuvant active specific immunotherapy of stage II and stage III colon cancer with an autologous tumor cell vaccine: First randomized phase III trials show promise
-
Hanna MG, Jr, Hoover HC, Jr, Vermorken JB, et al. Adjuvant active specific immunotherapy of stage II and stage III colon cancer with an autologous tumor cell vaccine: first randomized phase III trials show promise. Vaccine. 2001;19:2576-82.
-
(2001)
Vaccine
, vol.19
, pp. 2576-2582
-
-
Hanna Jr., M.G.1
Hoover Jr., H.C.2
Vermorken, J.B.3
-
16
-
-
9644303122
-
Colorectal cancer vaccines: Principles, results, and perspectives
-
Mocellin S, Rossi CR, Lise M, Nitti D. Colorectal cancer vaccines: principles, results, and perspectives. Gastroenterology. 2004;127:1821-37.
-
(2004)
Gastroenterology
, vol.127
, pp. 1821-1837
-
-
Mocellin, S.1
Rossi, C.R.2
Lise, M.3
Nitti, D.4
-
17
-
-
0035902607
-
Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immuno-therapy
-
Fong L, Hou Y, Rivas A, et al. Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immuno-therapy. Proc Natl Acad Sci USA. 2001;98:8809-14.
-
(2001)
Proc. Natl. Acad. Sci. USA
, vol.98
, pp. 8809-8814
-
-
Fong, L.1
Hou, Y.2
Rivas, A.3
-
18
-
-
20244366111
-
Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma
-
Dudley ME, Wunderlich JR, Yang JC, et al. Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. J Clin Oncol. 2005;23:2346-57.
-
(2005)
J. Clin. Oncol.
, vol.23
, pp. 2346-2357
-
-
Dudley, M.E.1
Wunderlich, J.R.2
Yang, J.C.3
-
19
-
-
33749624177
-
Cancer regression in patients after transfer of genetically engineered lymphocytes
-
Morgan RA, Dudley ME, Wunderlich JR, et al. Cancer regression in patients after transfer of genetically engineered lymphocytes. Science. 2006;314:126-9.
-
(2006)
Science
, vol.314
, pp. 126-129
-
-
Morgan, R.A.1
Dudley, M.E.2
Wunderlich, J.R.3
-
20
-
-
0035378334
-
A key role for ICAM-1 in generating effector cells mediating inflammatory responses
-
Camacho SA, Heath WR, Carbone FR, et al. A key role for ICAM-1 in generating effector cells mediating inflammatory responses. Nature Immunol. 2001;2:523-9.
-
(2001)
Nature Immunol.
, vol.2
, pp. 523-529
-
-
Camacho, S.A.1
Heath, W.R.2
Carbone, F.R.3
-
21
-
-
20044363610
-
CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells
-
Antony PA, Piccirillo CA, Akpinarli A, et al. CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells. J Immunol. 2005;174:2591-601.
-
(2005)
J. Immunol.
, vol.174
, pp. 2591-2601
-
-
Antony, P.A.1
Piccirillo, C.A.2
Akpinarli, A.3
-
22
-
-
19944430491
-
Tim-3+ T-bet+ tumor-specific Th1 cells colocalize with and inhibit development and growth of murine neoplasms
-
Simmons WJ, Koneru M, Mohindru M, et al. Tim-3+ T-bet+ tumor-specific Th1 cells colocalize with and inhibit development and growth of murine neoplasms. J Immunol. 2005;174:1405-15.
-
(2005)
J. Immunol.
, vol.174
, pp. 1405-1415
-
-
Simmons, W.J.1
Koneru, M.2
Mohindru, M.3
-
23
-
-
1642556833
-
T-bet regulates metastasis rate in a murine model of primary prostate cancer
-
Peng SL, Townsend MJ, Hecht JL, et al. T-bet regulates metastasis rate in a murine model of primary prostate cancer. Cancer Res. 2004;64:452-5.
-
(2004)
Cancer Res.
, vol.64
, pp. 452-455
-
-
Peng, S.L.1
Townsend, M.J.2
Hecht, J.L.3
-
24
-
-
29144514645
-
Effector memory T cells, early metastasis, and survival in colorectal cancer
-
Pages F, Berger A, Camus M, et al. Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med. 2005;353:2654-66.
-
(2005)
N. Engl. J. Med.
, vol.353
, pp. 2654-2666
-
-
Pages, F.1
Berger, A.2
Camus, M.3
-
25
-
-
30044434147
-
Priming of T cells by exogenous antigen cross-presented on MHC class I molecules
-
Shen L, Rock KL. Priming of T cells by exogenous antigen cross-presented on MHC class I molecules. Curr Opin Immunol. 2006;18:85-91.
-
(2006)
Curr. Opin. Immunol.
, vol.18
, pp. 85-91
-
-
Shen, L.1
Rock, K.L.2
-
26
-
-
0035905477
-
Cytokine-driven proliferation and differentiation of human naive, central memory, and effector memory CD4 (+) T cells
-
Geginat J, Sallusto F, Lanzavecchia A. Cytokine-driven proliferation and differentiation of human naive, central memory, and effector memory CD4 (+) T cells. J Exp Med. 2001;194:1711-9.
-
(2001)
J. Exp. Med.
, vol.194
, pp. 1711-1719
-
-
Geginat, J.1
Sallusto, F.2
Lanzavecchia, A.3
-
27
-
-
0141796316
-
Duration of antiviral immunity after smallpox vaccination
-
Hammarlund E, Lewis MW, Hansen SG, et al. Duration of antiviral immunity after smallpox vaccination. Nat Med. 2003;9:1131-7.
-
(2003)
Nat. Med.
, vol.9
, pp. 1131-1137
-
-
Hammarlund, E.1
Lewis, M.W.2
Hansen, S.G.3
-
28
-
-
0037174674
-
Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes
-
Dudley M, Wunderlich J, Robbins P, et al. Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science. 2002;298:850-4.
-
(2002)
Science
, vol.298
, pp. 850-854
-
-
Dudley, M.1
Wunderlich, J.2
Robbins, P.3
-
29
-
-
0034650421
-
Cutting edge: CD4+ T cell control of CD8+ T cell reactivity to a model tumor antigen
-
Surman DR, Dudley ME, Overwijk WW, Restifo NP. Cutting edge: CD4+ T cell control of CD8+ T cell reactivity to a model tumor antigen. J Immunol. 2000;164:562-5.
-
(2000)
J. Immunol.
, vol.164
, pp. 562-565
-
-
Surman, D.R.1
Dudley, M.E.2
Overwijk, W.W.3
Restifo, N.P.4
-
30
-
-
0032477815
-
Induction of antigen-specific T cell anergy: An early event in the course of tumor progression
-
Staveley-O'Carroll K, Sotomayor E, Montgomery J, et al. Induction of antigen-specific T cell anergy: an early event in the course of tumor progression. Proc Natl Acad Sci. 1998;95:1178-83.
-
(1998)
Proc. Natl. Acad. Sci.
, vol.95
, pp. 1178-1183
-
-
Staveley-O'Carroll, K.1
Sotomayor, E.2
Montgomery, J.3
-
31
-
-
0036569127
-
Cutting edge: Regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation
-
Woo EY, Yeh H, Chu CS, et al. Cutting edge: regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation. J Immunol. 2002;168:4272-6.
-
(2002)
J. Immunol.
, vol.168
, pp. 4272-4276
-
-
Woo, E.Y.1
Yeh, H.2
Chu, C.S.3
-
32
-
-
0036812718
-
Antigens derived from melanocyte differentiation proteins: Self-tolerance, autoimmunity, and use for cancer immunotherapy
-
Engelhard VH, Bullock TN, Colella TA, et al. Antigens derived from melanocyte differentiation proteins: self-tolerance, autoimmunity, and use for cancer immunotherapy. Immunol Rev. 2002;188:136-46.
-
(2002)
Immunol. Rev.
, vol.188
, pp. 136-146
-
-
Engelhard, V.H.1
Bullock, T.N.2
Colella, T.A.3
-
33
-
-
0033056073
-
Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients
-
Lee PP, Yee C, Savage PA, et al. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Nat Med. 1999;5:677-85.
-
(1999)
Nat. Med.
, vol.5
, pp. 677-685
-
-
Lee, P.P.1
Yee, C.2
Savage, P.A.3
-
35
-
-
33748076467
-
Tumour-induced immune modulation of sentinel lymph nodes
-
Cochran AJ, Huang RR, Lee J, et al. Tumour-induced immune modulation of sentinel lymph nodes. Nat Rev Immunol. 2006;6:659-70.
-
(2006)
Nat. Rev. Immunol.
, vol.6
, pp. 659-670
-
-
Cochran, A.J.1
Huang, R.R.2
Lee, J.3
-
36
-
-
34548144472
-
Palliative chemotherapy for advanced or metastatic colorectal cancer. Colorectal meta-analysis collaboration
-
Best L, Simmonds P, Baughan C, Buchanan R, Davis C, Fentiman I, et al. Palliative chemotherapy for advanced or metastatic colorectal cancer. Colorectal Meta-analysis Collaboration. Cochrane Database Syst Rev. 2000: CD001545.
-
(2000)
Cochrane Database Syst. Rev.
-
-
Best, L.1
Simmonds, P.2
Baughan, C.3
Buchanan, R.4
Davis, C.5
Fentiman, I.6
-
38
-
-
34249677872
-
Adoptive transfer of tumor-primed, in vitro-activated, CD4+ T effector cells (TEs) combined with CD8+ TEs provides intratumoral TE proliferation and synergistic antitumor response
-
Wang LX, Shu S, Disis ML, Plautz GE. Adoptive transfer of tumor-primed, in vitro-activated, CD4+ T effector cells (TEs) combined with CD8+ TEs provides intratumoral TE proliferation and synergistic antitumor response. Blood. 2007;109:4865-76.
-
(2007)
Blood
, vol.109
, pp. 4865-4876
-
-
Wang, L.X.1
Shu, S.2
Disis, M.L.3
Plautz, G.E.4
-
39
-
-
45549099784
-
Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1
-
Hunder NN, Wallen H, Cao J, et al. Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1. N Engl J Med. 2008;358:2698-703.
-
(2008)
N. Engl. J. Med.
, vol.358
, pp. 2698-2703
-
-
Hunder, N.N.1
Wallen, H.2
Cao, J.3
|